Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: September 11, 2009
Event: Regulation FD Disclosure regarding a presentation at the Thomas Weisel Partners Healthcare Conference 2009 in Boston.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report serves as a disclosure notice that such information is contained within attached presentation materials (Exhibit 99.1) rather than the text of the 8-K itself.
Material Changes and Updates
The presentation materials attached to this filing contain previously non-public information regarding:
- The anticipated timing and effects of global stimulus programs on Bruker.
- The Company's financial goals for 2009.
- The preliminary outlook for the Bruker Scientific Instruments (BSI) segment for 2010.
- Medium- and longer-term margin goals for the BSI segment.
Guidance, Outlook, and Risks
Outlook: Management provided a preliminary outlook for the BSI segment for 2010 and outlined medium- to long-term margin goals.
Regulatory Status: The information in this Current Report, including exhibits, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act. It is not subject to the liabilities of that Section and shall not be deemed incorporated by reference into any other filing unless specifically identified as such.
Investor Verification Checklist
- Review Exhibit 99.1 (September 11, 2009 Thomas Weisel Partners Healthcare Conference Presentation) for specific financial figures and guidance.
- Verify the specific impact of global stimulus programs on the company's operations as detailed in the presentation slides.
- Confirm the preliminary 2010 outlook for the BSI segment against actual performance in subsequent filings.
- Check the Company's investor relations website (http://ir.bruker.com) for the posted presentation materials.